+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma



A multi-institutional analysis of sequential versus 'sandwich' adjuvant chemotherapy and radiotherapy for stage IIIC endometrial carcinoma



Journal of Gynecologic Oncology 30(3): E28



To analyze the outcomes of sequential or sandwich chemotherapy (ChT) and radiotherapy (RT) in patients with node-positive endometrial cancer (EC). Data from 4 centers were collected retrospectively for 179 patients with stage IIIC EC treated with postoperative RT and ChT (paclitaxel and carboplatin). Patients were either treated with 6 cycles of ChT followed by RT (sequential arm; 96 patients) or with 3 cycles of ChT, RT, and an additional 3 cycles of ChT (sandwich arm; 83 patients). Prognostic factors affecting overall survival (OS) and progression-free survival (PFS) were analyzed. The 5-year OS and PFS rates were 64% and 59%, respectively, with a median follow-up of 41 months (range, 5-167 months). The 5-year OS rates were significantly higher in the sandwich than sequential arms (74% vs. 56%; p=0.03) and the difference for 5-year PFS rates was nearly significant (65% vs. 54%; p=0.05). In univariate analysis, treatment strategy, age, International Federation of Gynecology and Obstetrics (FIGO) stage, pathology, rate of myometrial invasion, and grade were prognostic factors for OS and PFS. In multivariate analysis, non-endometrioid histology, advanced FIGO stage, and adjuvant sequential ChT and RT were negative predictors for OS, whereas only non-endometrioid histology was a prognostic factor for PFS. Postoperative adjuvant ChT and RT for stage IIIC EC patients, either given sequentially or sandwiched, offers excellent clinical efficacy and acceptably low toxicity. Our data support the superiority of the sandwich regimen compared to the sequential strategy in stage IIIC EC patients for OS.

Please choose payment method:






(PDF emailed within 0-6 h: $19.90)

Accession: 066604222

Download citation: RISBibTeXText

PMID: 30887753

DOI: 10.3802/jgo.2019.30.e28


Related references

Comparison of "sandwich chemo-radiotherapy" and six cycles of chemotherapy followed by adjuvant radiotherapy in patients with stage IIIC endometrial cancer: a single center experience. Archives of Gynecology and Obstetrics 288(4): 845-850, 2013

A single institution experience using sequential multi-modality adjuvant chemotherapy and radiation in the "sandwich" method for high risk endometrial carcinoma. Gynecologic Oncology 118(1): 19-23, 2010

Single-Institution Comparison of Sandwich Versus Sequential Adjuvant Chemotherapy and Radiation for Stage III Endometrioid Uterine Carcinoma. International Journal of Radiation Oncology*biology*physics 90(1): S494-S495, 2014

Chemotherapy (CT) with radiotherapy versus CT alone for FIGO Stage IIIc endometrial cancer. European Journal of Gynaecological Oncology 30(1): 40-44, 2009

Adjuvant radiotherapy and survival outcomes in early-stage endometrial cancer: a multi-institutional analysis of 608 women. Gynecologic Oncology 103(2): 661-666, 2006

Prognostic Significance of Nodal Location and Ratio in Stage IIIC Endometrial Carcinoma Among a Multi-Institutional Academic Collaboration. American Journal of Clinical Oncology 41(12): 1220-1224, 2018

Role of adjuvant radiotherapy in FIGO stage IIIC endometrial carcinoma: Treatment outcomes and prognostic factors in 52 irradiated patients. Journal of the Formosan Medical Association 117(7): 613-620, 2018

Three versus six cycles of adjuvant platinum-based chemotherapy in early stage clear cell ovarian carcinoma - A multi-institutional cohort. Gynecologic Oncology 144(2): 274-278, 2017

Stereotactic body radiotherapy with adjuvant systemic therapy for early-stage non-small cell lung carcinoma: A multi-institutional analysis. RadioTherapy and Oncology 132: 188-196, 2019

Sequential chemotherapy and radiotherapy in the sandwich method for advanced endometrial cancer: a meta-analysis. Medicine 94(16): E672, 2015

Adjuvant Pelvic Radiotherapy vs. Sequential Chemoradiotherapy for High-Risk Stage I-II Endometrial Carcinoma. Cancer Biology and Medicine 9(3): 168-171, 2012

Sandwich therapy for the treatment of stage IIIC endometrial carcinoma: A community-based experience. Gynecologic Oncology 143(1): 220-221, 2016

Adjuvant Radiotherapy versus Combined Sequential Chemotherapy followed by Radiotherapy in the Treatment of Resected Nonsmall Cell Lung Carcinoma: A randomized trial of 267 patients. Cancer 76(5): 779-786, 1995

Adjuvant External Radiation Impacts Outcome of Pelvis-limited Stage III Endometrial Carcinoma: A Multi-institutional Study. American Journal of Clinical Oncology 41(8): 792-796, 2018

The importance of adjuvant chemotherapy and pelvic radiotherapy in high-risk early stage endometrial carcinoma. Gynecologic Oncology 131(3): 581-585, 2013